My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients.

    de Bandt M, Fautrel B, Maillefert JF, Berthelot JM, Combe B, Flipo RM, Lioté F, Meyer O, Saraux A, Wendling D, Le Loët X, Guillemin F; STPR group of the French Society of Rheumatology.

    Arthritis Res Ther. 2009;11(5):R157. Epub 2009 Oct 23.

    PMID:
    19849865
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    2.

    An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.

    van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR.

    Clin Ther. 2009 Aug;31(8):1737-46. Review.

    PMID:
    19808132
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?

    Soubrier M, Zerkak D, Gossec L, Ayral X, Roux C, Dougados M.

    J Rheumatol. 2006 Jul;33(7):1243-6. Epub 2006 Apr 15.

    PMID:
    16622906
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    The gap between practice and guidelines in the choice of first-line disease modifying antirheumatic drug in early rheumatoid arthritis: results from the ESPOIR cohort.

    Benhamou M, Rincheval N, Roy C, Foltz V, Rozenberg S, Sibilia J, Schaeverbeke T, Bourgeois P, Ravaud P, Fautrel B.

    J Rheumatol. 2009 May;36(5):934-42. Epub 2009 Mar 13.

    PMID:
    19286850
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    5.

    Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.

    Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL.

    Ann Rheum Dis. 2009 Jun;68(6):954-60. Epub 2008 May 19.

    PMID:
    18490431
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    6.

    Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.

    Carli C, Ehlin AG, Klareskog L, Lindblad S, Montgomery SM.

    Ann Rheum Dis. 2006 Aug;65(8):1102-5. Epub 2005 Dec 1.

    PMID:
    16322085
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    7.

    Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology.

    Le Loët X, Berthelot JM, Cantagrel A, Combe B, De Bandt M, Fautrel B, Flipo RM, Lioté F, Maillefert JF, Meyer O, Saraux A, Wendling D, Guillemin F.

    Ann Rheum Dis. 2006 Jan;65(1):45-50. Epub 2005 Jun 30.

    PMID:
    15994280
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    8.

    Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.

    Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM, Lioté F, Maillefert JF, Wendling D, Saraux A, Combe B, Le Loët X; Stratégies Thérapeutiques dans La Polyarthrite RhumatoIde Working Group; Club Rhumatismes et Inflammation; French Society of Rheumatology.

    Arthritis Rheum. 2009 Apr 15;61(4):425-34.

    PMID:
    19333993
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    9.

    Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.

    van Hulst LT, Kievit W, van Bommel R, van Riel PL, Fraenkel L.

    Arthritis Care Res (Hoboken). 2011 Oct;63(10):1407-14. doi: 10.1002/acr.20551.

    PMID:
    21748861
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis.

    Gonzalez-Alvaro I, Carmona L, Balsa A, Sanmarti R, Belmonte MA, Tena X; EMECAR Study Group.

    J Rheumatol. 2003 Apr;30(4):697-704.

    PMID:
    12672186
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.

    Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, Singh G, Yamanaka H.

    Ann Rheum Dis. 2008 Aug;67(8):1153-8. Epub 2007 Oct 30.

    PMID:
    17971459
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis.

    Mäkinen H, Kautiainen H, Hannonen P, Möttönen T, Leirisalo-Repo M, Laasonen L, Korpela M, Blåfield H, Hakola M, Sokka T.

    J Rheumatol. 2007 Feb;34(2):316-21. Epub 2006 Dec 15.

    PMID:
    17183623
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial.

    Fransen J, Moens HB, Speyer I, van Riel PL.

    Ann Rheum Dis. 2005 Sep;64(9):1294-8. Epub 2005 Apr 13.

    PMID:
    15829574
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    14.

    Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.

    Meyer O, de Bandt M, Berthelot JM, Cantagrel A, Combe B, Fautrel B, Flipo RM, Lioté F, Maillefert JF, Saraux A, Wendling D, Guillemin F, Le Loët X; Working Group for Therapeutic Strategies for Rheumatoid Arthritis.

    Joint Bone Spine. 2007 Jan;74(1):73-8. Epub 2006 Nov 29.

    PMID:
    17194614
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability.

    Pascual-Ramos V, Contreras-Yáñez I, Villa AR, Cabiedes J, Rull-Gabayet M.

    Arthritis Res Ther. 2009;11(1):R26. Epub 2009 Feb 19.

    PMID:
    19228421
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

    16.

    Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting.

    Vázquez I, Graell E, Gratacós J, Cañete JD, Viñas O, Ercilla MG, Gómez A, Hernández MV, Rodríguez-Cros JR, Larrosa M, Sanmartí R.

    Clin Exp Rheumatol. 2007 Mar-Apr;25(2):231-8.

    PMID:
    17543147
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.

    Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, Woodworth T, Gomez-Reino JJ.

    Arthritis Rheum. 2008 Oct;58(10):2968-80.

    PMID:
    18821691
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    18.

    Development and validation of a patient-based disease activity score in rheumatoid arthritis that can be used in clinical trials and routine practice.

    Choy EH, Khoshaba B, Cooper D, MacGregor A, Scott DL.

    Arthritis Rheum. 2008 Feb 15;59(2):192-9.

    PMID:
    18240256
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

    19.

    Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.

    Zink A, Listing J, Ziemer S, Zeidler H; German Collaborative Arthritis Centres.

    J Rheumatol. 2001 Oct;28(10):2201-8.

    PMID:
    11669156
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.

    Khanna D, Oh M, Furst DE, Ranganath V, Gold RH, Sharp JT, Park GS, Keystone EC, Paulus HE; Western Consortium of Practicing Rheumatologists.

    Arthritis Rheum. 2007 Apr 15;57(3):440-7.

    PMID:
    17394230
    [PubMed - indexed for MEDLINE]
    Free Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filter your results:

      Find related data

      Recent activity

      You are here: NCBI > Literature > PubMed
      Write to the Help Desk